购物车
- 全部删除
- 您的购物车当前为空
Dornidazole (PR-000350, PR-350, RP-343, PR-69) is an effective radiosensitizer for hypoxic cells with the potential for the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer.
Dornidazole (PR-000350, PR-350, RP-343, PR-69) is an effective radiosensitizer for hypoxic cells with the potential for the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 18,900 | 6-8周 | |
50 mg | ¥ 24,800 | 6-8周 | |
100 mg | ¥ 28,500 | 6-8周 |
产品描述 | Dornidazole (PR-000350, PR-350, RP-343, PR-69) is an effective radiosensitizer for hypoxic cells with the potential for the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. |
别名 | RP-343, PR-350, PR350, PR-000350, PR000350 |
分子量 | 247.21 |
分子式 | C8H13N3O6 |
CAS No. | 161903-10-2 |
密度 | 1.62 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容